{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:38:24Z","timestamp":1772537904554,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 DK-109940"],"award-info":[{"award-number":["K24 DK-109940"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Radiol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00256-018-3066-6","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T08:35:46Z","timestamp":1536914146000},"page":"773-779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states"],"prefix":"10.1007","volume":"48","author":[{"given":"F. Joseph","family":"Simeone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel P.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth K.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noopur S.","family":"Raje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Torriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam A.","family":"Bredella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"issue":"11","key":"3066_CR1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046\u201360.","journal-title":"N Engl J Med"},{"issue":"22","key":"3066_CR2","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113(22):5412\u20137.","journal-title":"Blood"},{"issue":"8","key":"3066_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346(8):564\u20139.","journal-title":"N Engl J Med"},{"issue":"12","key":"3066_CR4","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3066_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/bjh.12346","volume":"162","author":"JC Regelink","year":"2013","unstructured":"Regelink JC, Minnema MC, Terpos E, Kamphuis MH, Raijmakers PG, Pieters-van den Bos IC, et al. Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review. Br J Haematol. 2013;162(1):50\u201361.","journal-title":"Br J Haematol"},{"issue":"1","key":"3066_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1148\/radiol.2311020452","volume":"231","author":"EJ Angtuaco","year":"2004","unstructured":"Angtuaco EJ, Fassas AB, Walker R, Sethi R, Barlogie B. Multiple myeloma: clinical review and diagnostic imaging. Radiology. 2004;231(1):11\u201323.","journal-title":"Radiology"},{"issue":"21","key":"3066_CR7","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1001\/jama.2010.1713","volume":"304","author":"O Landgren","year":"2010","unstructured":"Landgren O, Waxman AJ. Multiple myeloma precursor disease. JAMA. 2010;304(21):2397\u2013404.","journal-title":"JAMA"},{"issue":"2","key":"3066_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0009-9260(67)80010-2","volume":"18","author":"GA Edelstyn","year":"1967","unstructured":"Edelstyn GA, Gillespie PJ, Grebbell FS. The radiological demonstration of osseous metastases. Experimental observations. Clin Radiol. 1967;18(2):158\u201362.","journal-title":"Clin Radiol"},{"issue":"4","key":"3066_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2214\/ajr.184.4.01841199","volume":"184","author":"MA Bredella","year":"2005","unstructured":"Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005;184(4):1199\u2013204.","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"3066_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","volume":"25","author":"R Walker","year":"2007","unstructured":"Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy JD Jr, et al. Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol. 2007;25(9):1121\u20138.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3066_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2967\/jnumed.111.098830","volume":"53","author":"RC Walker","year":"2012","unstructured":"Walker RC, Brown TL, Jones-Jackson LB, De Blanche L, Bartel T. Imaging of multiple myeloma and related plasma cell dyscrasias. J Nucl Med. 2012;53(7):1091\u2013101.","journal-title":"J Nucl Med"},{"issue":"7","key":"3066_CR12","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.ejrad.2014.02.008","volume":"83","author":"MB Wolf","year":"2014","unstructured":"Wolf MB, Murray F, Kilk K, Hillengass J, Delorme S, Heiss C, et al. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease. Eur J Radiol. 2014;83(7):1222\u201330.","journal-title":"Eur J Radiol"},{"issue":"3","key":"3066_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00256-008-0607-4","volume":"38","author":"TG Gleeson","year":"2009","unstructured":"Gleeson TG, Moriarty J, Shortt CP, Gleeson JP, Fitzpatrick P, Byrne B, et al. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skeletal Radiol. 2009;38(3):225\u201336.","journal-title":"Skeletal Radiol"},{"issue":"3","key":"3066_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/01.rct.0000237820.41549.c9","volume":"31","author":"J Hur","year":"2007","unstructured":"Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS. Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography. J Comput Assist Tomogr. 2007;31(3):342\u20137.","journal-title":"J Comput Assist Tomogr"},{"issue":"4","key":"3066_CR15","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3892\/ol.2017.5723","volume":"13","author":"L Lambert","year":"2017","unstructured":"Lambert L, Ourednicek P, Meckova Z, Gavelli G, Straub J, Spicka I. Whole-body low-dose computed tomography in multiple myeloma staging: superior diagnostic performance in the detection of bone lesions, vertebral compression fractures, rib fractures and extraskeletal findings compared to radiography with similar radiation exposure. Oncol Lett. 2017;13(4):2490\u20134.","journal-title":"Oncol Lett"},{"issue":"18","key":"3066_CR16","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351(18):1860\u201373.","journal-title":"N Engl J Med"},{"issue":"1","key":"3066_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"3066_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ajh.21191","volume":"83","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Dingli D, Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, et al. Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: results from a matched pair analysis. Am J Hematol. 2008;83(8):614\u20137.","journal-title":"Am J Hematol"},{"issue":"2","key":"3066_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2141.2008.07069.x","volume":"141","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Dingli D, Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, et al. Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders. Br J Haematol. 2008;141(2):205\u201311.","journal-title":"Br J Haematol"},{"issue":"5","key":"3066_CR20","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","volume":"111","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008;111(5):2516\u201320.","journal-title":"Blood"},{"issue":"2","key":"3066_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejrad.2004.04.015","volume":"54","author":"M Horger","year":"2005","unstructured":"Horger M, Claussen CD, Bross-Bach U, Vonthein R, Trabold T, Heuschmid M, et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol. 2005;54(2):289\u201397.","journal-title":"Eur J Radiol"},{"issue":"8","key":"3066_CR22","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/cncr.22572","volume":"109","author":"M Horger","year":"2007","unstructured":"Horger M, Kanz L, Denecke B, Vonthein R, Pereira P, Claussen CD, et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer. 2007;109(8):1617\u201326.","journal-title":"Cancer"},{"issue":"3","key":"3066_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/07357907.2013.764565","volume":"31","author":"K Princewill","year":"2013","unstructured":"Princewill K, Kyere S, Awan O, Mulligan M. Multiple myeloma lesion detection with whole body CT versus radiographic skeletal survey. Cancer Investig. 2013;31(3):206\u201311.","journal-title":"Cancer Investig"},{"issue":"2","key":"3066_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.diii.2012.12.001","volume":"94","author":"R Duvauferrier","year":"2013","unstructured":"Duvauferrier R, Valence M, Patrat-Delon S, Brillet E, Niederberger E, Marchand A, et al. Current role of CT and whole body MRI in multiple myeloma. Diagn Interv Imaging. 2013;94(2):169\u201383.","journal-title":"Diagn Interv Imaging"},{"issue":"10","key":"3066_CR25","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2009-03-213280","volume":"114","author":"TB Bartel","year":"2009","unstructured":"Bartel TB, Haessler J, Brown TL, Shaughnessy JD Jr, van Rhee F, Anaissie E, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood. 2009;114(10):2068\u201376.","journal-title":"Blood"},{"issue":"4","key":"3066_CR26","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, et al. Role of (18)F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017;18(4):e206\u201317.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3066_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00259-011-1993-8","volume":"39","author":"T Derlin","year":"2012","unstructured":"Derlin T, Weber C, Habermann CR, Herrmann J, Wisotzki C, Ayuk F, et al. 18F-FDG PET\/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation. Eur J Nucl Med Mol Imaging. 2012;39(3):493\u2013500.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"3066_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1600-0609.2010.01575.x","volume":"86","author":"BM Elliott","year":"2011","unstructured":"Elliott BM, Peti S, Osman K, Scigliano E, Lee D, Isola L, et al. Combining FDG-PET\/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma. Eur J Haematol. 2011;86(4):289\u201398.","journal-title":"Eur J Haematol"},{"issue":"17","key":"3066_CR29","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.18632\/oncotarget.2290","volume":"5","author":"C Lapa","year":"2014","unstructured":"Lapa C, Luckerath K, Malzahn U, Samnick S, Einsele H, Buck AK, et al. 18 FDG-PET\/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation. Oncotarget. 2014;5(17):7381\u201391.","journal-title":"Oncotarget"},{"issue":"25","key":"3066_CR30","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1200\/JCO.2017.72.2975","volume":"35","author":"P Moreau","year":"2017","unstructured":"Moreau P, Attal M, Caillot D, Macro M, Karlin L, Garderet L, et al. Prospective evaluation of magnetic resonance imaging and [(18)F]Fluorodeoxyglucose positron emission tomography-computed tomography at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM\/DFCI 2009 trial: results of the IMAJEM study. J Clin Oncol. 2017;35(25):2911\u20138.","journal-title":"J Clin Oncol"},{"issue":"23","key":"3066_CR31","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1182\/blood-2011-06-361386","volume":"118","author":"E Zamagni","year":"2011","unstructured":"Zamagni E, Patriarca F, Nanni C, Zannetti B, Englaro E, Pezzi A, et al. Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood. 2011;118(23):5989\u201395.","journal-title":"Blood"},{"issue":"4","key":"3066_CR32","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2214\/AJR.07.2635","volume":"190","author":"A Baur-Melnyk","year":"2008","unstructured":"Baur-Melnyk A, Buhmann S, Becker C, Schoenberg SO, Lang N, Bartl R, et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. AJR Am J Roentgenol. 2008;190(4):1097\u2013104.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"3066_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.78","volume":"7","author":"J Hillengass","year":"2017","unstructured":"Hillengass J, Moulopoulos LA, Delorme S, Koutoulidis V, Mosebach J, Hielscher T, et al. Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the international myeloma working group. Blood Cancer J. 2017;7(8):e599.","journal-title":"Blood Cancer J"},{"issue":"1","key":"3066_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00330-007-0738-3","volume":"18","author":"P Kropil","year":"2008","unstructured":"Kropil P, Fenk R, Fritz LB, Blondin D, Kobbe G, Modder U, et al. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma. Eur Radiol. 2008;18(1):51\u20138.","journal-title":"Eur Radiol"},{"issue":"4","key":"3066_CR35","first-page":"147","volume":"3","author":"B Wirk","year":"2012","unstructured":"Wirk B, Bush CH, Hou W, Pettiford L, Moreb JS. Detection of skeletal lesions by whole body multidetector computed tomography in multiple myeloma has no impact on long-term outcomes post autologous hematopoietic cell transplantation. World J Oncol. 2012;3(4):147\u201357.","journal-title":"World J Oncol"},{"issue":"12","key":"3066_CR36","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.ejrad.2013.08.036","volume":"82","author":"D Ippolito","year":"2013","unstructured":"Ippolito D, Besostri V, Bonaffini PA, Rossini F, Di Lelio A, Sironi S. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM). Eur J Radiol. 2013;82(12):2322\u20137.","journal-title":"Eur J Radiol"}],"container-title":["Skeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-018-3066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00256-018-3066-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-018-3066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T10:41:05Z","timestamp":1589625665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00256-018-3066-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3066"],"URL":"https:\/\/doi.org\/10.1007\/s00256-018-3066-6","relation":{},"ISSN":["0364-2348","1432-2161"],"issn-type":[{"value":"0364-2348","type":"print"},{"value":"1432-2161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]},"assertion":[{"value":"19 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived for this retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}